Quarterly report · Q2
4587.TEDINET S100OZ1E
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 65
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.0bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.6bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥9.4bn | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.9bn | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.4bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS |
| Operating income | −¥1.6bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | −¥393m | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥436m | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥442m | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥361m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.8bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥312m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥352m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥227m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥8m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥213m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥227m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥2.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | −¥8m | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥213m | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥51.9bn | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥27.0bn | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥24.8bn | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥26.1bn | at 2020-12-31d | Cons. | Assets IFRS |
| Total liabilities | ¥27.2bn | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.7bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥4.9bn | at 2020-12-31d | Cons. | Liabilities IFRS |
| Net assets / equity | ¥24.7bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥25.4bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥22.6bn | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥21.3bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥24.7bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥25.4bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥22.6bn | at 2021-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥21.3bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥6.4bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.8bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥7.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥10m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.7bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥5.0bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥26.7bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥2.3bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥450m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥66m | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥45m | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-8.13 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-1.75 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.96 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-0.07 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥1.66 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-8.13 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-1.75 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.81 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-0.07 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥1.64 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 47.7% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 93.8% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 91.3% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 9
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E27486-000Drug Discovery And Development Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.4bn |
| jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥3.9bn |
| jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥3.9bn |
| jpcrp040300-q2r_E27486-000Radiopharmaceuticals Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥198m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥5.0bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥5.0bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 668
| Item | Context | Value | Unit |
|---|---|---|---|
| Retained earnings IFRS | Prior1YearInstant | 16372687000 | JPY |
| Retained earnings IFRS | CurrentQuarterInstant | 15316606000 | JPY |
| Other components of equity IFRS | Prior2YearInstant | 191468000 | JPY |
| Other components of equity IFRS | Prior1YearInstant | 1188589000 | JPY |
| Other components of equity IFRS | CurrentQuarterInstant | 1621761000 | JPY |
| Equity attributable to owners of parent IFRS | Prior2YearInstant | 21278808000 | JPY |
| Equity attributable to owners of parent IFRS | Prior1YearInstant | 25350250000 | JPY |
| Equity attributable to owners of parent IFRS | CurrentQuarterInstant | 24739352000 | JPY |
| Equity IFRS | Prior2YearInstant | 21278808000 | JPY |
| Equity IFRS | Prior1YearInstant | 25350250000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 24739352000 | JPY |
| Liabilities and equity IFRS | Prior2YearInstant | 26140976000 | JPY |
| Liabilities and equity IFRS | Prior1YearInstant | 27034596000 | JPY |
| Liabilities and equity IFRS | CurrentQuarterInstant | 51895583000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 2916946000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 5024397000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 962469000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 3003772000 | JPY |
| Gross profit IFRS | Prior1YTDDuration | 1954476000 | JPY |
| Gross profit IFRS | CurrentYTDDuration | 2020624000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YTDDuration | 776214000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYTDDuration | 2425234000 | JPY |
| Research and development expenses IFRS | Prior1YTDDuration | 770906000 | JPY |
| Research and development expenses IFRS | CurrentYTDDuration | 1154597000 | JPY |
| Other income IFRS | Prior1YTDDuration | 29054000 | JPY |
| Other income IFRS | CurrentYTDDuration | 518000 | JPY |
| Other expenses IFRS | Prior1YTDDuration | 179000 | JPY |
| Other expenses IFRS | CurrentYTDDuration | 1000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 436230000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | -1559688000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 235513000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 250800000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | － | JPY |
| Finance costs IFRS | CurrentYTDDuration | 66104000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | -359567000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | -109972000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 312177000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | -1484964000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 320513000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | -428883000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | -8335000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | -1056081000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | -8335000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | -1056081000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | -8335000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | -1056081000 | JPY |
| Basic earnings loss per share IFRS | Prior1YTDDuration | -0.07 | |
| Basic earnings loss per share IFRS | CurrentYTDDuration | -8.13 | |
| Diluted earnings loss per share IFRS | Prior1YTDDuration | -0.07 | |
| Diluted earnings loss per share IFRS | CurrentYTDDuration | -8.13 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |